Periodic Reporting for period 1 - glyCoVdrugs (Inverting α-glucosidase inhibitors as potential drugs for SARS-CoV-2)

The project aimed to address an urgent global health need by developing new approaches to combat viral infections such as SARS-CoV-2, the virus responsible for COVID-19. The focus was on creating inhibitors that target α-glucosidase enzymes, which are essential for the...